These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002912-27 Open-Label Extension Study to Investigate the Continued Safety and Effect of ONO 2506PO (1200 mg OD). not-yet-due
Listed as ongoing, but also has a completion date 2006-002660-26 A MULTI-CENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ONO-2506PO COMPARED TO PLACEBO, IN THE PRESENCE OF RILUZOLE, TO PATIENTS DIAGNO... 2008-09-03 bad-data
Not reported 2007-002417-39 A MULTI-CENTRE RANDOMISED DOUBLE BLIND, PLACEBO AND ACTIVE CONTROLLED PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ONO-5334 IN POST MENOPAUSAL WOMEN WITH OSTEOPENIA OR OSTEOPOROSIS 2010-08-26 due-trials
Listed as ongoing, but also has a completion date 2007-004723-37 A Phase II multi-centre, extension study to investigate the long term safety of ONO-2506PO in patients diagnosed with Amyotrophic Lateral Sclerosis (ALS). 2008-09-03 bad-data
Not reported 2007-006538-33 A RANDOMISED, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED, 5-WAY, PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ONO-8539 IN PATIENTS WITH OVERACTIVE BLADD... 2010-05-25 due-trials
Listed as ongoing, but also has a completion date 2009-014339-19 A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ONO-4641 IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS 2011-11-29 bad-data
Reported results 2010-018705-11 A SAFETY AND EFFICACY EXTENSION STUDY OF ONO-4641 IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS 2015-01-30 due-trials
Not reported 2012-002273-54 A randomised, double-blind, placebo controlled, double dummy, four period crossover study to evaluate the efficacy, safety and tolerability of oral repeat doses of ONO-4053 and Cetirizine in subjects ... 2013-03-12 due-trials
Ongoing 2015-003339-36 A Multicenter, Randomized, Open-label Study in Patients with esophageal Cancer refractory or intolerant to Combination Therapy with Fluoropyrimidine and Platinum-based Drugs not-yet-due
Completed, reported early 2016-002675-97 A randomised, double-blind, placebo controlled, parallel group, multi-centre, study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ONO-4474 in patients with pain due to osteoar... 2018-01-09 not-yet-due
Trial is outside EEC, and reported results 2018-000662-11 ONO-7436 Phase III Study – A multicenter, open-label, uncontrolled study for the prevention of chemotherapy-induced nausea and vomiting bad-data
Trial is outside EEC, and reported results 2018-000663-80 ONO-7847 Japanese Clinical Study in Pediatric Patients Multicenter, open-label, uncontrolled study for the prevention of CINV bad-data